Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes
Terence T. Sio(The University of Texas MD Anderson Cancer Center), Steven J. Frank(The University of Texas MD Anderson Cancer Center), William H. Morrison(The University of Texas MD Anderson Cancer Center), Pierre Blanchard(Inserm), G. Brandon Gunn(The University of Texas MD Anderson Cancer Center), David I. Rosenthal(The University of Texas MD Anderson Cancer Center), Charles S. Cleeland(The University of Texas MD Anderson Cancer Center), Xin Shelley Wang(The University of Texas MD Anderson Cancer Center), Tito R. Mendoza(The University of Texas MD Anderson Cancer Center), Radhe Mohan(The University of Texas MD Anderson Cancer Center), Qiuling Shi(The University of Texas MD Anderson Cancer Center), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), Adam S. Garden(The University of Texas MD Anderson Cancer Center), Nikhil G. Thaker, Mike Hernández(The University of Texas MD Anderson Cancer Center), J. Jack Lee(The University of Texas MD Anderson Cancer Center), Huei-Kai Lin(The University of Texas MD Anderson Cancer Center), Jack Phan(The University of Texas MD Anderson Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
February 18, 2016
Cited by 172
Related Papers
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
|The Lancet Oncology|2016|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation
|International Journal of Radiation Oncology*Biology*Physics|1995|458